Nystatin A3

Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.

Cross Reference

Introduction

To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Nystatin A3?

Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Nystatin A3

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Otitis Externa D010032 8 associated lipids
Burns D002056 34 associated lipids
Body Weight D001835 333 associated lipids
Peritonitis D010538 38 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Vaginitis D014627 6 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Dermatomycoses D003881 17 associated lipids
Pregnancy Complications, Infectious D011251 11 associated lipids
Aspergillosis D001228 5 associated lipids
Leishmaniasis D007896 19 associated lipids
HIV Seropositivity D006679 15 associated lipids
Influenza, Human D007251 11 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Candidiasis, Oral D002180 11 associated lipids
Mycoses D009181 18 associated lipids
Gonorrhea D006069 7 associated lipids
Xerostomia D014987 6 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Urethritis D014526 9 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Blastomycosis D001759 5 associated lipids
Candidemia D058387 2 associated lipids
Per page 10 20 50 | Total 25

PubChem Associated disorders and diseases

What pathways are associated with Nystatin A3

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Nystatin A3?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Nystatin A3?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Nystatin A3?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Nystatin A3?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Nystatin A3?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Nystatin A3

Download all related citations
Per page 10 20 50 100 | Total 1594
Authors Title Published Journal PubMed Link
Jakab Á et al. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy. 2015 J. Basic Microbiol. pmid:25707543
Okechukwu DC et al. Evaluation of the anti-candidal activity of methanolic leaf extract of cleistopholis patens (fam. Annonaceae) on candida species isolated from stage II HIV patients. 2015 Afr Health Sci pmid:26957966
Mobasheri M et al. Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. 2015 Molecules pmid:26712721
de Castro RD et al. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. 2015 BMC Complement Altern Med pmid:26601661
Dewan E et al. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. 2015 Hematol Oncol Stem Cell Ther pmid:26173033
de Castro RD et al. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins. 2015 BMC Oral Health pmid:25928798
Bassi P and Kaur G Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. 2015 Eur J Pharm Biopharm pmid:26235393
Cui H et al. Functional manipulations of the tetramycin positive regulatory gene ttmRIV to enhance the production of tetramycin A and nystatin A1 in Streptomyces ahygroscopicus. 2015 J. Ind. Microbiol. Biotechnol. pmid:26233316
Franiczek R et al. β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin. 2015 Med. Mycol. pmid:26092104
Bodin MB et al. Topical Nystatin for the Prevention of Catheter-Associated Candidiasis in ELBW Infants. 2015 Adv Neonatal Care pmid:25938952
Boros-Majewska J et al. A novel in vitro assay for assessing efficacy and toxicity of antifungals using human leukaemic cells infected with Candida albicans. 2015 J. Appl. Microbiol. pmid:25845720
Trindade LA et al. Inhibition of adherence of C. albicans to dental implants and cover screws by Cymbopogon nardus essential oil and citronellal. 2015 Clin Oral Investig pmid:25804885
Farrag HA et al. Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis. 2015 Int. J. Radiat. Biol. pmid:25758055
Korany MA et al. Application of derivative spectrophotometry under orthogonal polynomial at unequal intervals: determination of metronidazole and nystatin in their pharmaceutical mixture. 2015 Spectrochim Acta A Mol Biomol Spectrosc pmid:25748283
Schulz JC et al. Unfolding and folding internal friction of β-hairpins is smaller than that of α-helices. 2015 J Phys Chem B pmid:25741584
Urban VM et al. Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials. 2015 J Prosthodont pmid:25082183
Kandile NG and Zaky HT New pyrano[2,3-c]pyridazine derivatives with antimicrobial activity synthesized using piperidine as the organocatalyst. 2015 J Enzyme Inhib Med Chem pmid:24666292
Bueno MG et al. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm. 2015 Oral Dis pmid:24219354
Sharifzadeh A et al. Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. 2015 Mycoses pmid:26152466
Al-Shayyab MH et al. Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan. 2015 Int Dent J pmid:26148537